Darifenacin 46708-0224
Product NDC
46708-0224- Manufacturer
- Alembic Pharmaceuticals Limited
- Dosage Form
- Tablet, Extended Release
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- December 12, 2017
- Listing Expires
- December 31, 2026
- Application
- ANDA207681
Need to source Darifenacin? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Darifenacin Hydrobromide | 15 mg/1 |
Drug Class
Cholinergic Muscarinic Antagonist [EPC]Cholinergic Muscarinic Antagonists [MoA]
Packaging Options(4)
8 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (46708-224-08)
30 TABLET, EXTENDED RELEASE in 1 BOTTLE (46708-224-30)
90 TABLET, EXTENDED RELEASE in 1 BOTTLE (46708-224-90)
1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (46708-224-91)